Adverse Events and Complications Associated With Intrathecal Drug Delivery Systems: Insights From the Manufacturer and User Facility Device Experience (MAUDE) Database

Modern intrathecal drug delivery systems (IDDS) are technologically advanced to deliver medication through various automated and patient‐controlled programs. They also are associated with unique complications ranging from post‐operative complications, medication‐related adverse events (AE), device malfunction, to refill associated AE.

[1]  H. Shankar,et al.  Response to Letter to the Editor Regarding: “Adverse Events and Complications Associated With Intrathecal Drug Delivery Systems: Insights From the Manufacturer and User Facility Device Experience (MAUDE) Database” , 2021, Neuromodulation : journal of the International Neuromodulation Society.

[2]  T. Chan,et al.  Machine learning for pattern detection in cochlear implant FDA adverse event reports , 2020, medRxiv.

[3]  R. M. Singa,et al.  A Comparison of Refill Procedures and Patient Outcomes Following Ultrasound‐Guided and Template‐Guided Intrathecal Drug Delivery Systems With Recessed Ports , 2019, Neuromodulation : journal of the International Neuromodulation Society.

[4]  B. Paskhover,et al.  Investigating Complications Associated With Occipital Nerve Stimulation: A MAUDE Study , 2018, Neuromodulation : journal of the International Neuromodulation Society.

[5]  R. Perez,et al.  Intrathecal Pump Refills, Pocket Fills, and Symptoms of Drug Overdose: A Prospective, Observational Study Comparing the Injected Drug Volume vs. the Drug Volume Effectively Measured Inside the Pump , 2017, Neuromodulation : journal of the International Neuromodulation Society.

[6]  M. Saulino,et al.  The Polyanalgesic Consensus Conference (PACC): Recommendations for Intrathecal Drug Delivery: Guidance for Improving Safety and Mitigating Risks , 2017, Neuromodulation : journal of the International Neuromodulation Society.

[7]  P. Konrad,et al.  Intrathecal Drug Delivery Systems (IDDS): The Implantable Systems Performance Registry (ISPR) , 2016, Neuromodulation : journal of the International Neuromodulation Society.

[8]  T. Lamer,et al.  Surgical Site Infections in Cancer Patients with Intrathecal Drug Delivery Devices , 2016, Pain medicine.

[9]  P. Christo,et al.  Current perspectives on intrathecal drug delivery , 2014, Journal of pain research.

[10]  A. Patil,et al.  Axial (central) downward herniation of the brain as a complication of intra-thecal drug delivery system (IDDS) implant – A case report , 2014, Clinical Neurology and Neurosurgery.

[11]  Robert Levy,et al.  Best Practices for Intrathecal Drug Delivery for Pain , 2014, Neuromodulation : journal of the International Neuromodulation Society.

[12]  N. Tran,et al.  Increasing back and radicular pain 2 years following intrathecal pump implantation with review of arachnoiditis. , 2013, Pain medicine.

[13]  Jason S. Eldrige,et al.  Post dural puncture headache following intrathecal drug delivery system placement. , 2013, Pain physician.

[14]  R. Gebhardt,et al.  SynchroMed II intrathecal pump memory errors due to repeated magnetic resonance imaging. , 2012, Pain physician.

[15]  H. Shankar.  Ultrasound‐Guided Localization of Difficult‐to‐Access Refill Port of the Intrathecal Pump Reservoir , 2009, Neuromodulation : journal of the International Neuromodulation Society.

[16]  R. Owen,et al.  Intrathecal granuloma in a patient receiving high dose hydromorphone. , 2008, Pain physician.

[17]  B. T. Sitzman.  Adverse Event Protocol for Interventional Pain Medicine: The Importance of an Organized Response , 2008 .

[18]  C. F. Barnett,et al.  Introduction of Infection Control Measures to Reduce Infection Associated With Implantable Pain Therapy Devices , 2007, Pain practice : the official journal of World Institute of Pain.

[19]  P. Staats,et al.  An implantable drug delivery system (IDDS) for refractory cancer pain provides sustained pain control, less drug-related toxicity, and possibly better survival compared with comprehensive medical management (CMM). , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[20]  S. Kamran,et al.  Complications of Intrathecal Drug Delivery Systems , 2001, Neuromodulation : journal of the International Neuromodulation Society.

[21]  B. Huh,et al.  Magnetic fields and intrathecal pump malfunction. , 2016, The American journal of emergency medicine.